Table 2. Clinicopathological characteristics of the further validation-set of colorectal.
| Characteristics | N = 438 |
|---|---|
| Age (years) | |
| < 60 | 201 (45.9%) |
| ≥ 60 | 237 (54.1%) |
| Gender | |
| Male | 230 (52.5%) |
| Female | 208 (47.5%) |
| Tumor Differentiation | |
| Poor | 58 (13.2%) |
| Moderate | 343 (78.3%) |
| Well | 37 (8.4%) |
| LN metastasis | |
| Negative | 244 (55.7%) |
| Positive | 194 (44.3%) |
| Distant metastasis | |
| Negative | 311 (71.0%) |
| Positive | 127 (29.0%) |
| Liver metastasis | |
| Negative | 321 (73.1%) |
| Positive | 117 (26.9%) |
| TNM Stage | |
| I | 62 (14.2%) |
| II | 169 (38.6%) |
| III | 161 (36.8%) |
| IV | 46 (10.5%) |
| pMKK4 score | |
| Low (–/+) | 320 (73.1%) |
| High (++/+++) | 118 (26.9%) |
(N = 438).